TABLE 3.

Comparison of Growth Rates in Department of Health and Human Services Programs and Core Funding Levels

	Percentage of Gross Domestic Producta				Percentage of Real per Capita Expenditureabc
	FY2008–2009, Req Growth Rate	FY1998–2008, Growth Rate	FY1998–2009, Req Growth Rate	FY2001–2002, Growth Rate	FY2008–2009, Req Growth Rate	FY1998–2008, Growth Rate	FY1998–2009, Req Growth Rate	FY2001–2002, Growth Rate
Total expendituresd
FDA	1.9	2.6	2.6	14.2	3.0	4.4	4.3	14.3
HRSA	−17.5	1.3	−0.6	−0.2	−16.6	3.0	1.1	−0.1
CDC	−7.9	8.3	6.7	49.5	−6.9	10.2	8.5	49.8
NIH	−3.6	2.7	2.1	11.2	−2.6	4.5	3.8	11.4
Core fundingdefg
FDA	0.05	1.5	1.4	3.3	1.1	3.3	3.1	3.5
HRSA	−17.5	1.3	−0.6	−2.3	−16.6	3.0	1.1	−2.2
CDC	−8.0	6.4	5.0	2.1	−7.0	8.3	6.8	2.2
NIH	−3.7	2.1	1.5	10.1	−2.6	3.9	3.2	10.3

Note. FY = fiscal year; Req = requested; FDA = Food and Drug Administration; HRSA = Health Resources and Services Administration; CDC = Centers for Disease Control and Prevention; NIH = National Institutes of Health. Funding annualized with the compound annual growth rate. Growth comparisons are based on program-level agency funding data, a more inclusive (and as a result, more conservative) budget presentation. Table includes President's FY09 Budget Request. Core funding excludes biopreparedness funding for illustrative pro forma purposes—some observers have questioned whether biopreparedness funding directly or fully contributes to basic or essential public health activities.

^aCongressional Budget Office, Analysis of the President's Budgetary Proposals for Fiscal Year 2009 and related tables.¹⁵

^bStatistical Abstract of the United States, 2008.¹⁶

^cAdjusted with the implicit price deflator for gross domestic product (FY2000 = $100.0). Price index source: Congressional Budget Office (2008).¹⁷

^dUS Department of Health and Human Services, Budget in Brief, 1999 to 2008.²¹

^ePublic Budget Database, Office of Management and Budget, February 2008.¹⁹

^fBioterrorism: Federal Research and Preparedness Activities, Government Accountability Office, GAO-01-915 (September 2001).²²

^gFranco and Deitch, “Billions for biodefense.”²³